NCT06710756: An ongoing trial by Perspective Therapeutics
This trial is ongoing. It must report results 3 years, 1 month from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06710756 |
|---|---|
| Title | A Phase I/IIa Image-Guided, Alpha-Particle Therapy Study of [203Pb]Pb-PSV359 and [212Pb]Pb-PSV359 in Patients With Solid Tumors That Are Known to be Fibroblast Activation Protein (FAP)-Positive |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 28, 2025 |
| Completion date | Jan. 31, 2028 |
| Required reporting date | Jan. 30, 2029, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 3, 2025 |
| Days late | None |